TROUBLING RESEARCH REVEALED AT 12TH KEELE CONFERENCE ON ALUMINUM
Every other year, for more than two decades, a small group of 70 or so scientists have been meeting at different locales across the globe to discuss their speciality: aluminum and its effects on living things.
The science of a metal used in industries from airplane manufacturing to food packaging may sound tedious, but this three-day Keele meeting (named for Keele University in the United Kingdom where it originated) produces a treasure trove of valuable information about the health impact of aluminium exposure. It’s a conference of the latest science that the $186 billion aluminum industry denies and public health agencies pretend does not exist.
The 12th Annual Keele Meeting on Aluminum in March 2017 in Vancouver, Canada, sponsored by the Children’s Medical Safety Research Institute, was no exception. Scientists from 16 countries discussed the latest research about how aluminum impacts plants, animals and humans. We inhale it in pollution, consume it in processed foods, slather it on in toiletries and inject it into ourselves and our babies in vaccines. Neurotoxic aluminium, according to increasing amount of scientific evidence, may stay in the body where it breaches protective barriers, induces wildly oxidative processes and fires inflammation, disrupts genetic transcription, impairs metabolism, accumulates in brain and breasts and testes, is linked to cancer, infertility, Alzheimer’s disease and anxious, aggressive and autistic behaviour.
“Some people think it is harmless, but everyone at Keele understands the toxicity of aluminium,” said Keele biologist and aluminum expert Christopher Exley who launched the meeting. His research started three decades ago when he began looking into why fish exposed to aluminum in their water died within 24 hours.
Aluminum may be the third most abundant element on earth, said Exley, “but for most of its history, it has been sequestered by silica. It’s only in the last few decades that we’ve managed to put it into biological systems.”
And in the last few decades, as aluminum production has soared globally, research on the health consequences of that industry has steadily accumulated.
Aluminum safety myths
The keynote address of the conference was given by Romain Gherardi from the Neuromuscular Pathology Expert Centre at Paris-Est Créteil University (UPEC) who gave a frightening overview of the most novel and profound aluminum research related to vaccination.
Aluminium oxyhydroxide (Alhydrogel), and Aluminium hydroxyphosphate (Adjuphos), are nanomaterials widely used as immune stimulants or “adjuvants” of vaccines. Children have received them in increasing doses from the hepatitis B shot on their day of birth, in diphtheria-tetanus shots given repeatedly in their first six months of life and in pneumococcal, meningitis, HPV vaccines and more.
In at least seven different countries, patients with myalgic chronic fatigue syndrome have been described after they received one of these aluminum-containing vaccines. In France in the late ’90s, Gherardi began taking biopsies of the deltoid muscle of these patients and he discovered lesions in these – clumps of aggregated aluminium hydroxide engulfed in white blood cells called macrophages — at the injection site. Subsequent studies in mice found that aluminum in these cells slowly migrates to their brains where it seems to prefer to settle, permanently. He called the phenomenon Macrophagic Myofasciitis (MMF).
------------------------------------
This excerpt above from CMSRI's excellent essay posted by Vexman, along with other worthwhile and diverse subject matter written by Vexman as well as from other sources:
Vexman's Thoughts
Every other year, for more than two decades, a small group of 70 or so scientists have been meeting at different locales across the globe to discuss their speciality: aluminum and its effects on living things.
The science of a metal used in industries from airplane manufacturing to food packaging may sound tedious, but this three-day Keele meeting (named for Keele University in the United Kingdom where it originated) produces a treasure trove of valuable information about the health impact of aluminium exposure. It’s a conference of the latest science that the $186 billion aluminum industry denies and public health agencies pretend does not exist.
The 12th Annual Keele Meeting on Aluminum in March 2017 in Vancouver, Canada, sponsored by the Children’s Medical Safety Research Institute, was no exception. Scientists from 16 countries discussed the latest research about how aluminum impacts plants, animals and humans. We inhale it in pollution, consume it in processed foods, slather it on in toiletries and inject it into ourselves and our babies in vaccines. Neurotoxic aluminium, according to increasing amount of scientific evidence, may stay in the body where it breaches protective barriers, induces wildly oxidative processes and fires inflammation, disrupts genetic transcription, impairs metabolism, accumulates in brain and breasts and testes, is linked to cancer, infertility, Alzheimer’s disease and anxious, aggressive and autistic behaviour.
“Some people think it is harmless, but everyone at Keele understands the toxicity of aluminium,” said Keele biologist and aluminum expert Christopher Exley who launched the meeting. His research started three decades ago when he began looking into why fish exposed to aluminum in their water died within 24 hours.
Aluminum may be the third most abundant element on earth, said Exley, “but for most of its history, it has been sequestered by silica. It’s only in the last few decades that we’ve managed to put it into biological systems.”
And in the last few decades, as aluminum production has soared globally, research on the health consequences of that industry has steadily accumulated.
Aluminum safety myths
The keynote address of the conference was given by Romain Gherardi from the Neuromuscular Pathology Expert Centre at Paris-Est Créteil University (UPEC) who gave a frightening overview of the most novel and profound aluminum research related to vaccination.
Aluminium oxyhydroxide (Alhydrogel), and Aluminium hydroxyphosphate (Adjuphos), are nanomaterials widely used as immune stimulants or “adjuvants” of vaccines. Children have received them in increasing doses from the hepatitis B shot on their day of birth, in diphtheria-tetanus shots given repeatedly in their first six months of life and in pneumococcal, meningitis, HPV vaccines and more.
In at least seven different countries, patients with myalgic chronic fatigue syndrome have been described after they received one of these aluminum-containing vaccines. In France in the late ’90s, Gherardi began taking biopsies of the deltoid muscle of these patients and he discovered lesions in these – clumps of aggregated aluminium hydroxide engulfed in white blood cells called macrophages — at the injection site. Subsequent studies in mice found that aluminum in these cells slowly migrates to their brains where it seems to prefer to settle, permanently. He called the phenomenon Macrophagic Myofasciitis (MMF).
------------------------------------
This excerpt above from CMSRI's excellent essay posted by Vexman, along with other worthwhile and diverse subject matter written by Vexman as well as from other sources:
Vexman's Thoughts
Last edited:
